Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, August 16, 2010

Cancer epigenomics: Implications of DNA methylation in personalized cancer therapy - Cancer Science

Note: in research; see Table 1 for references to ovarian cancer/cisplatin

"Methylation of FANCF has been found in 20% of primary ovarian cancers not previously exposed to cisplatin, but the correlation between chemosensitivity and FANCF methylation in primary tumors remains to be determined."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.